Vascular pathology from smoking: Look at the microcirculation!

Current Vascular Pharmacology

Volumn 11, Issue 4, 2013, Pages 524-530

  Leone, Aurelio ^a,b   Landini, Linda ^a  

^a UNIVERSITY OF PISA   (Italy)

^b City Hospital Massa   (Italy)

Author keywords

Carbon monoxide; Cardiomyopathy; Microcirculation; Nicotine; Smoking

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; NICOTINE; THIOCYANATE;

ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL INJURY; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE FIBROSIS; HUMAN; HYPOXIA; MICROCIRCULATION; NONHUMAN; SMOKING; VASCULAR DISEASE;

ANIMALS; ATHEROSCLEROSIS; BRAIN; CARBON MONOXIDE; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY; MICROCIRCULATION; NICOTINE; REGIONAL BLOOD FLOW; SMOKING; THROMBOEMBOLISM;

EID: 84882781272     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161111311040016     Document Type: Article

References (97)

1. Leone A. Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: risk of cardiovascular disease and preventive measures. Curr Pharm Des 2003; 9: 2417-23.
2. Leone A, Giannini D, Bellotto C, Balbarini A. Passive smoking and coronary heart disease. Curr Vasc Pharmacol 2004; 2: 175-82.
3. Powell JT. Vascular damage from smoking: diseases mechanisms at the arterial wall. Vasc Med 1998; 3: 21-8.
4. Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology 2003; 54: 507-30.
5. Stefanidis C, Vlachopoulos C, Tsiamis E. Unfavourable effects of passive smoking in aortic function in men. Ann Intern Med 1998; 128: 426-34.
6. Leone A. Cardiovascular damage from smoking: a fact or belief? Int J Cardiol 1993; 38: 113-7.
7. Leone A. Smoking and hypertension: Independent or additive effects to determining vascular damage? Curr Vasc Pharmacol 2011; 9: 585-93.
8. Astrup P. Carbon monoxide, smoking and cardiovascular disease. Circulation 1973; 48: 1167-8.
9. Eliot RS, Baroldi G, LeoneA. Necropsy studies in myocardial infarction with minimal or no coronary luminal reduction due to atherosclerosis. Circulation 1974; 49: 1127-31.
10. Auerbach O, Carter HW, Garfinkel L, Hammond EC. Cigarette smoking and coronary heart disease: a macroscopic and microscopic study. Chest 1976; 70: 697-705.
11. Cryer PE, Haymond MV, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smokingassociated hemodynamic and metabolic events. N Engl J Med 1976; 295: 573-7.
12. Moreyra AE, Lacy CR, Wilson AC, Kumar A, Kostis JB. Arterial blood nicotine concentrations and coronary vasoconstrictive effect of low-nicotine cigarette smoking. Am Heart J 1992; 124: 392-7.
13. Quillen JE, Rossen JD, Oskarsson HJ, et al. Acute effect of cigarette smoking on the coronary circulation constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993; 22: 642-7.
14. Jeremy JY. Smoking and vascular defense mechanisms. J Smoking-Related Disord 1994; 5: 49-54.
15. Byrd JC. Environmental tobacco smoke. Medical and legal issues. Med Clini North Am 1992; 76: 377-97.
16. Armitage AK, Turner DM. Absorption of nicotine in cigarette and cigar smoke through the oral mucosa. Nature 1970; 226: 1231-2.
17. Leone A, Landini L, Leone A. What is tobacco smoke? Sociocultural dimensions of the association with cardiovascular risk. Curr Pharm Des 2010; 16: 2510-7.
18. Glantz SA, Parmley WW. Passive smoking and heart disease: epidemiology, physiology, and biochemistry. Circulation 1991; 83: 1-12.
19. Leone A. Biochemical markers of passive smoking. In: Passive Smoking and Cardiovascular Pathology, Mechanisms and Physiopathological Basis of Damage, A Leone ed, Nova Science Publishers Inc, New York 2007; 19-37.
20. Adams JD, Erickson HH, Stone HL. Myocardial metabolism during exposure carbon monoxide in the conscious dog. J Appl Physiol 1973; 34: 238-42.
21. Horwath SM, Raven PB, Dahms TE, Gray DJ. Maximal aerobic capacity at different levels of carboxyhemoglobin. J Appl Physiol 1975; 38: 300-3.
22. Lewey FH, Drabkin DD. Experimental chronic carbon monoxide poisoning of dogs. Am J Med Sci 1944; 208: 502-11.
23. Anderson RF, Allensworth DC, DeGroot WJ. Myocardial toxicity from carbon monoxide poisoning. Ann Intern Med 1967; 11: 72-82.
24. Thomsen HK, Kjeldsen K. Threshold limit for carbon monoxideinduced myocardial damage. Arch Environ Health 1974; 29: 73-8.
25. Apple FS. Serum thiocyanate concentrations in patients with normal or impaired renal function receiving nitroprusside. Clin Chem 1996; 42: 1878-9.
26. De la Higuera AJ. Determination of serum thiocyanate in patients with thyroid disease using a modification of the Aldridge method. J Anal Toxicol 1994; 18: 58-9.
27. Olea F, Parras P. Determination of serum levels of dietary thiocyanate. J Anal Toxicol 1992; 16: 258-60.
28. Schwartz CJ. Structure and function of the circulation. Vol 1, Plenum Pub Cop, New York, 1980.
29. Leone A, Landini L Jr, Biadi O, Balbarini A. Smoking and cardiovascular system: Cellular features of the damage. Curr Pharm Des 2008; 14: 1771-7.
30. Kjeldsen K, Thomsen H, Astrup P. Effects of carbon monoxide on myocardium: Ultrastructural changes in rabbits after moderate chronic exposure. Circ Res 1974; 34: 339-48.
31. Leone A. Biochemical markers of cardiovascular damage from tobacco smoke. Curr Pharm Des 2005; 11: 2199-208.
32. Beard DA, Wu F, Cabrera ME, Dash RK. Modeling of cellular metabolism and microcirculatory transport. Microcirculation 2008; 15: 777-93.
33. Black HR, Zeevi GR, Silten RM, et al. Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 1983; 34: 173-9.
34. Oberai B, Adams CWM, High OB. Myocardial and renal arteriolar thickening in cigarette smokers. Atherosclerosis 1984; 52: 185-90.
35. Lough J. Cardiomyopathy produced by cigarette smoke. Ultrastructural observations in guinea pigs. Arch Pathol Lab Med 1978; 102: 377-86.
36. Kannel WB. Update on the role of cigarette smoking in coronary disease. Am Heart J 1981; 101: 319-28.
37. The Coronary Drug Project Research Group. Cigarette smoking as a risk factor in men with a prior history of myocardial infarction. J Chron Dis 1979; 32: 415-25.
38. Yong T, Zheng MQ, Linthicum DS. Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J Neuroimmunol 1997; 80: 158-64.
39. Wechsler RL. Effects of cigarette smoking and intravenous nicotine on the human brain. Fed Proc 1958: 17: 169a.
40. Lasner TM, Weil RJ, Riina HA, et al. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurismal subarachnoid hemorrhage. J Neurosurg 1997; 87: 381-4.
41. Mochizuchi M, Maruo T, Masuko K, et al. Effects of smoking on fetoplacental-maternal system during pregnancy. Am J Obstet Gynecol 1984; 149: 413-20.
42. Armussen I, Kjeldsen K. Intimal ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and non-smoking mothers. Circ Res 1975; 36: 579-89.
43. Muhlhauser I, Sawicki P, Berger M. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1986; 29: 500-2.
44. Stegmayr B, Lithner F. Tobacco and end stage diabetic nephropathy: BMJ 1987; 295: 581-2.
45. Klein R, Klein BEK, Davis MD. Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 1983; 118: 228-38.
46. Richardson DR. Effects of habitual tobacco smoking on reactive hyperemia in the human hand. Arch Environ Health 1985; 40: 114-9.
47. Hagen RL, D'Agostino JA. The effects of cigarette smoking on human sexual potency. Addict Behav 1986; 11: 431-4.
48. Jeremy JY, Mikhailidis DP. Cigarette smoking and erectile dysfunction. J R Soc Promot Health 1998; 118: 151-5.
49. Glina S, Reichelt AC, Leao PP, Dos Reis JM. Impact of cigarette smoking on papaverine-induced erection. J Urol 1988; 140: 523-4.
50. McFarland RA. The effects of exposure to small quantities of carbon monoxide on vision. Ann NY Acad Sci 1970; 174: 301-12.
51. Benignus VA, Kafer ER, Muller KE, Case MW. Absence of symptoms with carboxyhemoglobin levels of 16-23%. Neurotoxicol Teratol 1987; 9: 345-8.
52. Leone A, Mori L, Bertanelli F, Fabiano P, Filippelli F. Indoor passive smoking: its effect on cardiac performance. Int J Cardiol 1991; 8: 247-52.
53. Leone A, Bertanelli F, Mori L, Fabiano P, Bertoncini G. Ventricular arrhythmias by passive smoking in patients with pre-existing myocardial infarction. J Am Coll Cardiol 1992; 3: 256A.
54. Ehrich WE, Bellet S, Lewey FH. Cardiac changes from CO poisoning. Am J Med Sci 1944; 208; 512-23.
55. Astrup P. Some physiological and pathological effects of moderate carbon monoxide exposure. BMJ 1972; 4: 447-52.
56. Leone A. Does smoking act as a friend or enemy of blood pressure? Let release Pandora's box. Cardiology Research and Practice Volume 2011, Article ID 264894, 7 pages, doi:10.4061/2011/264894.
57. Strong JP, Richards ML, McGill HR Jr. On the association of cigarette smoking with coronary and aortic atherosclerosis. J Atheroscler Res 1969; 10: 303-17.
58. Glantz SA, Parmley WW. Passive smoking and heart disease. JAMA 1995; 273: 1047-53.
59. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol 1994; 24: 546-54.
60. Mikhailidis DP, Barradas MA, Nystrom ML, Jeremy JY. Cigarette smoking increases with blood cell aggregation in whole blood. J R Soc Med 1993; 86: 680-1.
61. Leone A, Lopez M. Oral contraception, ovarian disorders and tobacco in myocardial infarction of woman. Pathologica 1986; 78: 237-42.
62. Lu K, Bjorkhem I, Xiu RJ, Henriksson P, Freyschuss A. Nacetylcysteine improves microcirculatory flow during smoking: new effects of an old drug with possible benefits for smokers. Clin Cardiol 2001; 24: 511-5.
63. Miura H, Toyama K, Pratt PF, Gutterman DD. Cigarette smoking impairs Na+-K+-ATPase activity in the human coronary microcirculation. AJP-Heart 2011; 300 (A): H109-H117.
64. Robbins & Cotrans Pathologic Basis of Disease. Morphology of arteriolosclerosis, Kumar V, Abbas AK, Fausto N and Aster J eds, 8th edition, Elsevier, Amsterdam 2009; 495-6.
65. Wanstrup J, Kjeldsen K, Astrup P. Acceleration of spontaneous intimal-subintimal changes in rabbit aorta by a prolonged moderate carbon monoxide exposure. Acta Pathol Microbiol Scand 1969; 75: 353-62.
66. Mosely LH, Finseth MDF. Cigarette smoking: impairment of digital blood flow and wound healing in the hand. Hand 1977; 9: 97-101.
67. Hugod C, Hawkins L, Kjeldsen K, Thomsen H, Astrup P. Effect of carbon monoxide exposure on aortic and coronary intimal morphology in the rabbit. A revaluation. Atherosclerosis 1978; 30: 333-42.
68. Bajusz E, Jasmin G. Observations on histochemical differentialdiagnosis between primary and secondary cardiomyopathies. Am Heart J 1965; 69: 83-92.
69. Hill P, Wynder L. Smoking and cardiovascular disease. Am Heart J 1974; 87: 491-6.
70. Cantin M, Leone A. Morphology of myocardial infarction. Meth Achiev Exp Pathol 1981; 10: 244-84.
71. Schlessinger MJ, Reiner L. Focal myocytolysis of the heart. Am J Pathol 1955; 31: 443-59.
72. Sommers HM, Jennings RB. Experimental acute myocardial infarction. Histologic and histochemical studies of early myocardial infarction induced by temporary or permanent occlusion of a coronary artery. Lab Invest 1964; 13: 1491-503.
73. Roggendorf W, Neumann H, Thorn HL, Schneider H, Sarasa-Corral JL. Histologic examination of the rat after long-term exposure to subtoxic automotive exhaust gas. Arch Toxicol 1981; 47: 247-56.
74. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388-98.
75. Felker GM, Thompson R, Hare J, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-84.
76. Schmermund A, Baumgart D, Gorge G, et al. Coronary artery calcium in acute coronary syndromes. Circulation 1997; 96: 1461-9.
77. Leone A, Bertanelli F, Mori L, Fabiano P, Battaglia A. Features of ischaemic cardiac pathology resulting from cigarette smoking. J Smoking-Related Dis 1994; 5: 109-14.
78. Auerbach O, Hammond EC, Garfinkel L. Thickening of walls of arterioles in relation to age and smoking habits. N Engl J Med 1968; 278: 980-4.
79. Auerbach O, Garfinkel L. Myocardial mural arterial fibrosis and cigarette smoking: a comparative study 1955-1960 vs. 1970-1977. Bull NY Acad Med 1981; 57: 759-75.
80. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med 1989; 149: 386-9.
81. Celermajer DS, Sorensen KE, Georgakopoulos D. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.
82. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-4.
83. Giannini D, Leone A, DiBisceglie D, et al. The effects of acute passive smoke exposure on endothelium-dependent brachial artery dilation in healthy individuals. Angiology 2007; 58: 211-7.
84. Leone A. Five markers capable to identify passive smoking exposure associated with endothelial dysfunction in healthy individuals. Curr Hypertens Rev 2008; 4: 183-9.
85. Deedwania PC. Endothelium: a new target for cardiovascular therapeutics. J Am Coll Cardiol 2000; 35: 67-70.
86. Furchgott RF. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. J Am Med Assn 1996; 276: 1186-8.
87. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and essential hypertension. Circulation 1995; 91: 1981-7.
88. Su C. Action of nicotine and smoking on circulation. Pharmacol Ther 1982; 17: 129-41.
89. Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993; 22 (Suppl 4): S1-S14.
90. Westfall TC, Brasted M. The mechanism of action of nicotine on adrenergic neurons in the perfused guinea-pig heart. J Pharmacol Exp Ther 1972; 182: 409-18.
91. Deanfield J. Passive smoking and early arterial damage. Eur Heart J 1996; 17: 645-6.
92. Winniford MD, Wheelan KR, Kremers MS, et al. Smokinginduced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986; 73: 662-7.
93. Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness. Arch Intern Med 1994; 154: 1277-82.
94. Ball K, Turner R. Smoking and the heart: the basis for action. Lancet 1974; 2: 822-6.
95. Benowitz NL, Jacob P III, Jones RT, Rosemberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 1982; 221: 368-72.
96. Doonan RJ, Hausvater A, Scallen C, Mikhailidis DP, Pilote L, Daskalopoulou SS. Effect of smoking on arterial stiffness. Hypertens Res 2010; 33: 398-410.
97. Santarelli MF, Landini L, Positano V, Landini L. Can imaging techniques identify smoking-related cardiovascular disease? Curr Pharm Des 2010; 16: 2578-85.